Matthew Gall - 03 Nov 2025 Form 3 Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Signature
/s/ Matthew Gall
Issuer symbol
KLRS
Transactions as of
03 Nov 2025
Net transactions value
$0
Form type
3
Filing time
03 Nov 2025, 17:23:04 UTC
Previous filing
29 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gall Matthew Chief Financial Officer C/O KALARIS THERAPEUTICS, INC., 400 CONNELL DRIVE SUITE 5500, BERKELEY HEIGHTS /s/ Matthew Gall 03 Nov 2025 0001816194

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney